CEPI expands Lassa fever study to four more West African countries - Homeland Preparedness News
© Shutterstock What is already the largest ever Lassa fever assessment study will expand to reach Benin, Guinea, Liberia, and Sierra Leone, thanks to an additional $10.3 million from the Coalition for Epidemic Preparedness Innovation (CEPI). "There have been a number of positive developments in the Lassa vaccine space over the past couple of years, with multiple candidates now moving into in-human testing," Melanie Saville, director of Vaccine Research and Development at CEPI, said. "To continue this momentum and to meet CEPI's goal to get a licensed Lassa vaccine for routine immunisation, we must therefore now advance our disease-assessment efforts to provide the critical data for future late-stage ...